Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Leukemia 5Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Primary Myelofibrosis 2Leukemia, Myelomonocytic, Chronic 2Anemia, Refractory, with Excess of Blasts 2Thrombocythemia, Essential 1Precancerous Conditions 1Polycythemia Vera 1Multiple Myeloma 1Mastocytosis, Systemic 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Graft vs Host Disease 1Congenital Abnormalities 1Blast Crisis 1Anemia, Refractory 1Anemia 1

Interventions

Cyclophosphamide 38Tacrolimus 35Methotrexate 29fludarabine phosphate 24Busulfan 24Cyclosporine 23Antilymphocyte Serum 23Mycophenolic Acid 20fludarabine 18Peripheral Blood Stem Cell Transplantation 18Melphalan 18Methylprednisolone 16Filgrastim 16Radiotherapy 15Sirolimus 14Whole-Body Irradiation 13thymoglobulin 8Stem Cell Transplantation 8Thiotepa 7Cord Blood Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 6Transplantation 5Hematopoietic Stem Cell Transplantation 5Flow Cytometry 5Etoposide 5Alemtuzumab 5Cyclosporins 4Bone Marrow Transplantation 4Therapeutics 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Thalidomide × Myeloid × Clear all
NCT00023530 2016-02-18

Blood and Marrow Transplant Clinical Research Network

National Heart, Lung, and Blood Institute (NHLBI)

Phase NA Completed
MyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hematologic Diseases, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡